Nutraceuticals Market Report, Revenue, Advancement Strategy and Geographical Performance Forecast to 2030
Nutraceuticals Market Overview:
The global nutraceuticals
market, valued at approximately USD 416 billion in 2026, is
projected to grow at a CAGR of around 9% over the next five years.
Key factors driving this growth include increasingly
sedentary lifestyles, a rapidly aging population, rising health awareness, and
growing demand for dietary and food supplements. Additional contributors
include the entry of pharmaceutical and food companies into the sector,
expanding applications of functional foods and beverages, rising disposable
incomes, and increased spending on health and wellness products. However, the
market faces notable challenges, particularly the proliferation of counterfeit
dietary supplements and growing consumer distrust stemming from misleading
advertising and communication practices, which may hinder market expansion.
Download Sample PDF Copy: https://meditechinsights.com/global-nutraceuticals-market/request-sample/
Nutraceuticals broadly refer to foods or food
components that provide additional medical or health benefits, including
disease prevention and treatment. The category primarily comprises dietary
supplements and functional foods and beverages. With shifting consumer
lifestyles and an increased focus on fitness and preventive healthcare, demand
for nutraceutical products continues to surge.
Nutraceuticals: Unlocking
Diversification Opportunities for Pharmaceutical and Food Companies
In recent years, pharmaceutical and food companies,
along with investors, have shown growing interest in the nutraceuticals market
due to its strong growth potential and attractive margins.
Pharmaceutical companies view nutrition as a strategic
and lucrative opportunity, enabling them to leverage existing capabilities such
as robust R&D infrastructure, clinical trial expertise, established
relationships with healthcare professionals, and access to scientific
databases. These strengths allow them to develop complementary nutrition
solutions aligned with existing drug therapies to improve patient outcomes.
Reflecting this potential, major pharmaceutical players including Pfizer,
Bayer, Otsuka Pharmaceutical, and Abbott have entered the nutraceuticals space.
Similarly, food and FMCG companies such as Nestlé,
Danone, and Amway have recognized the strategic value of nutraceuticals within
their portfolios. These companies are leveraging their expertise in nutrition
science, taste and flavor development, diverse product formats, agile
packaging, consumer insights, branding, marketing, and strong distribution
networks to establish a competitive presence in the market.
As noted by the Chair of Infectious Diseases at a
leading public research university in London, UK:
“The paradigm shift in healthcare from treatment to prevention is providing
momentum to the nutraceuticals market. This transition has encouraged patients
and consumers to rethink health and disease, creating opportunities for
pharmaceutical and food companies to engage across the disease and care
continuum.”
Download Sample PDF Copy: https://meditechinsights.com/global-nutraceuticals-market/request-sample/
Impact of COVID-19 on the Global
Nutraceuticals Market
The COVID-19 pandemic significantly accelerated demand
for nutraceuticals, particularly vitamins and supplements, following reports
that Vitamin D supplementation could reduce the risk of COVID-19 complications.
Research identifying Vitamin D as a potent immune-modulating micronutrient
further supported calls for increased supplementation and higher recommended
intake levels by governments. This led to a surge in demand for vitamins,
minerals, and herbal supplements, strengthening overall market growth.
Demand for dietary supplements and functional foods and
beverages continues to remain elevated as consumers increasingly prioritize
preventive healthcare, immunity, and overall wellbeing. Heightened awareness of
chronic diseases, nutrition, and immune health suggests that this trend is
likely to persist in the long term.
High-Potential Revenue Segments in the
Nutraceuticals Market
To address the growing prevalence of dementia,
neurodegenerative disorders such as Alzheimer’s disease, gut health concerns,
cardiovascular diseases, and diabetes, nutraceutical manufacturers are actively
developing targeted products. These include formulations designed to enhance
cognitive function, gluten- and lactose-free offerings, cholesterol-lowering
and heart-health products, and sugar substitutes suitable for diabetic
populations. A robust pipeline of such innovations is expected to further fuel
market growth.
Product Innovation Driving Market
Expansion
The nutraceuticals market is highly innovation-driven,
with continuous product advancements shaping competition. For example, in April
2022, PharmaLinea announced its next-generation product portfolio, including
new gut health solutions and UTI Free Orosticks. During the same period,
Wellbeing Nutrition launched SLOW, a first-of-its-kind time-release
nutraceutical range for men and women. The SLOW technology utilizes
sustained-release coated pellets within capsules to enable gradual nutrient
absorption throughout the day. The range includes 13 targeted supplements
addressing diverse health needs such as fertility support, bone health, weight
management, and daily nutrition.
Growth Strategies in the
Nutraceuticals Market
The market features a mix of established players and
emerging entrants, all of whom adopt both organic and inorganic growth
strategies—including product launches, partnerships, and acquisitions—to expand
their market share. Notable examples include Pharmactive Biotech Products’
strategic partnership with Singapore-based Nutraconnect Pte. Ltd. in June 2022
to introduce scientifically validated nutraceutical ingredients across the
Asia-Pacific region. In May 2022, Unilever announced the acquisition of a majority
stake in Nutrafol, a leading dermatologist-recommended hair growth supplement
brand.
Browse Report: https://meditechinsights.com/global-nutraceuticals-market/
Future Outlook
The global nutraceuticals market is expected to gain
further traction in the coming years, driven by widespread Vitamin D
deficiency, rising awareness of its role in bone and joint health, lifestyle
disease management, and overall wellbeing. Additional growth catalysts include
increasing participation of pharmaceutical and food companies, greater
influence of online medical platforms and international health organizations in
consumer education, and rising participation in professional and amateur sports
activities worldwide.
Competitive Landscape
The global nutraceuticals market is highly competitive,
with the presence of major players such as Archer Daniels Midland Company,
Herbalife Nutrition, Amway, Nestlé Health Science, Danone, Pfizer, Bayer,
Universal NutriScience, Innophos, and AOR Canada, among others.
Related Report:
Dental 3D Printing Market - https://www.pharmiweb.com/press-release/2026-01-30/dental-3d-printing-market-2030-size-share-growth-analysis-and-research-report-to-forecast
Antibody Testing Market - https://www.pharmiweb.com/press-release/2026-01-30/antibody-testing-market-growth-opportunities-sales-trends-service-applications-and-forecast-2030
Vaccine CDMO Market - https://www.pharmiweb.com/press-release/2026-01-30/vaccine-cdmo-market-strategy-revenue-opportunity-business-segment-overview-and-key-trends-2026-2030
Pulse Oximeter Market - https://www.pharmiweb.com/press-release/2026-01-30/pulse-oximeter-market-2026-growth-opportunities-sales-trends-service-applications-and-forecast-2030
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research &
insights firm. Our clients include Fortune 500 companies, blue-chip investors
& hyper-growth start-ups. We have completed 100+ projects in Digital
Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive
intelligence, market sizing and forecasting, pricing analysis &
go-to-market strategy. Our methodology includes rigorous secondary research
combined with deep-dive interviews with industry-leading CXO, VPs, and key
demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment